about
Improved cytotoxic T-lymphocyte immune responses to a tumor antigen by vaccines co-expressing the SLAM-associated adaptor EAT-2.Trial watch: Naked and vectored DNA-based anticancer vaccinesProtective anti-tumour immune responses by murine dendritic cells pulsed with recombinant Tat-carcinoembryonic antigen derived from Escherichia coli.Trial Watch: DNA vaccines for cancer therapy.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Carcinoembryonic antigen as a vaccine target.
@en
Carcinoembryonic antigen as a vaccine target.
@nl
type
label
Carcinoembryonic antigen as a vaccine target.
@en
Carcinoembryonic antigen as a vaccine target.
@nl
prefLabel
Carcinoembryonic antigen as a vaccine target.
@en
Carcinoembryonic antigen as a vaccine target.
@nl
P2093
P2860
P356
P1476
Carcinoembryonic antigen as a vaccine target.
@en
P2093
Dongmei Wang
John L Marshall
Shayan Rayani
P2860
P304
P356
10.1586/14760584.7.7.987
P577
2008-09-01T00:00:00Z